Pinned post
A new cover for SUPER AGERS after making the NYT bestseller list. Thanks to you for making it the #1 ranked new non-fiction book on Amazon.
amazon.com/gp/new-release…
amazon.com/gp/new-release…
Eric Topol
Verified account This account is verified. Learn more@EricTopol
physician-scientist, author of SUPER AGERS tinyurl.com/3w76us9a
and Ground Truths: erictopol.substack.com
and Ground Truths: erictopol.substack.com
695 Following 832K Followers 54K Posts
Latest posts 5
Is this a potential future strategy for primary prevention of atherosclerosis?
CRISPR base editing in vivo of the ANGPLT3 gene to achieve marked and durable lipid lowering.
Promising data in experimental models, including hon-human primates, moving on to clinical trials
@Nature nature.com/articles/s4158…
www.nature.com In Vivo CRISPR Base Editing of ANGPTL3 for Durable Lipid Lowering Nature - In Vivo CRISPR Base Editing of ANGPTL3 for Durable Lipid Lowering CRISPR base editing in vivo of the ANGPLT3 gene to achieve marked and durable lipid lowering.
Promising data in experimental models, including hon-human primates, moving on to clinical trials
@Nature nature.com/articles/s4158…
Today #AHA26 and @NEJM the 2 big trials of secondary prevention of heart disease with an IL-6 antibody and Lp(a) antisense oligonucleotide. No beneficial effect, overall and across all subgroups
nejm.org/doi/full/10.10…
nejm.org/doi/full/10.10…
nejm.org/doi/full/10.10…
nejm.org/doi/full/10.10…
Streaming on Substack Sunday morning Join us for a lively discussion about medicine, surgery, leadership and inspiration. Join us via the app.
🎙️ Happening Sunday at #ScientificSessions26!
Join @EricTopol, MD, and @JoChikweMD, FRCS, FAHA, for a live recording of the Ground Truths podcast.
📅 Nov. 8
⏰ 11:30 AM CT
📍Special Session Room
Stop by and listen in on the conversation shaping the future of healthcare and cardiovascular medicine.View quoted post on X
